LetsGetChecked Completes Acquisition of Truepill

Healthcare Investment Banker Aaron Schwimmer Joins MTS Health Partners as Partner in Life Sciences Group

Osivax and KM Biologics Enter Exclusive License Option Agreement for Broad-Spectrum “Universal” Influenza Vaccine in Japan

Pharmacosmos Group to Acquire G1 Therapeutics

Sharecare Enters Into Definitive Agreement to be Acquired by Altaris

Evan Matlin Joins MTS Health Partners as Partner in Life Sciences Group

Asahi Kasei to Acquire Calliditas Therapeutics AB to Accelerate Growth as a Global Healthcare Company

AltruBio Secures up to $225M Oversubscribed Series B Financing to Advance the Clinical Development of Novel Immune Checkpoint Enhancer Program

MTS Health Partners Adds Jason Schoenholtz as Healthcare Services Partner

AristaMD and Sitka Form Single Company, Secure Series C of $16.5M for the Expansion of Specialty Care Access via Electronic and Video Consultation Services

Redx Pharma: Proposed Subscription to raise c.£14.1 million

Harmony Biosciences to Acquire Zynerba Pharmaceuticals, Inc.

Revolution Medicines, Inc. to Acquire EQRx, Inc. in All-Stock Transaction to Gain More Than $1 Billion in Additional Capital

Big Health Expands into Adolescent Mental Health Through Acquisition of Limbix

Chinook Therapeutics Enters Into Agreement to be Acquired by Novartis AG

Sobi to Acquire CTI BioPharma Corp. Enhancing Sobi’s Position in Rare Haematology

Pfizer Invests $43 Billion to Battle Cancer

Sun Pharma to Acquire Concert Pharmaceuticals, Advancing the Potential Treatment of Alopecia Areata

Eisai to Divest Rights for Anti-epileptic Drug Fycompa® (perampanel) CIII in United States to Catalyst Pharmaceuticals

SCAN Group and CareOregon Announce Intent to Combine As HealthRight Group, a National Mission-Driven Healthcare Organization

BehaVR and OxfordVR Combine and Raise Series B to Create Largest VR Delivery Platform for Evidence-Based Digital Therapeutics

Minoryx and Neuraxpharm announce a strategic alliance to provide a new therapy for rare CNS disease patients in Europe

Aravive Announces Approximately $41.5 Million Private Placement Financing

Syncona to Acquire Applied Genetic Technologies Corporation

Jazz Pharmaceuticals And Zymeworks Announce Exclusive License Agreement To Develop And Commercialize Zanidatamab, A HER2-Targeted Bispecific Antibody

SOC Telemed Expands Behavioral Health Offering with Acquisition of Forefront Telecare; Company Renamed Access TeleCare

Ipsen to acquire Epizyme, expanding its portfolio in oncology

Lightbeam Acquires Jvion AI and SDoH Solutions

SCAN Acquires The Residentialist Group Launches Homebase Medical

Innoviva to Acquire Entasis Therapeutics

Pharos Capital Invests in Sanderling Renal Services, Adds Dialysis and Renal Telemedicine Services Platform to Portfolio

Brickell Biotech Announces Sale of Sofpironium Bromide to Botanix Pharmaceuticals

Vytalize Health Raises Over $50M Series B to Advance Value-Based Care

LYRA THERAPEUTICS ANNOUNCES $100.5 MILLION PRIVATE PLACEMENT

The Vistria Group Announces Majority Investment in Professional Health Care Network (PHCN)

Homology Medicines’ established AAV capabilities into a newly formed AAV Manufacturing and Innovation Business in the U.S. with Homology Medicines as 20% owner

Fujifilm Expands its Advanced Therapies CDMO Business with the Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.

ADC Therapeutics Announces Exclusive License with Mitsubishi Tanabe Pharma Corporation to Develop and Commercialize ZYNLONTA® (loncastuximab tesirine-lpyl) in Japan

Bellicum Announces Positive Interim Data from Phase 1/2 GoCAR-T® Studies, Secures $35 Million Private Placement Equity Financing Priced at Market

Sumitomo Dainippon Pharma and BehaVR announce landmark deal for multiple virtual reality digital therapeutics

Mnet Health Announces Acquisition of One Medical Passport, Inc.

Takeda to Commercialize Next-Generation Hunter Syndrome Therapy Through Collaboration with JCR Pharmaceuticals

Azurity Pharmaceuticals to Acquire and Merge with Arbor Pharmaceutical

Grifols signs an agreement with ImmunoTek to open 21 plasma centers and further advances on its expansion plan

Meridian Signs Definitive Agreement to Acquire Urea Breath Test for H. pylori from Otsuka America Pharmaceutical, Inc.

SERES THERAPEUTICS, NESTLÉ HEALTH SCIENCE ANNOUNCE SER-109 CO-COMMERCIALIZATION LICENSE AGREEMENT

Catalyst Pharmaceuticals Announces Exclusive License and Supply Agreement with DyDo Pharma for the Development and Commercialization of Firdapse® in Japan

MHH Healthcare, LLC to Acquire Medical Card System, Inc. (MCS), a Leading Healthcare Services Organization in Puerto Rico

Humana Announces Agreement to Acquire onehome

Xeris Pharmaceuticals, Inc. to Acquire Strongbridge Biopharma plc in Stock and CVR Transaction, Creating an Innovative Leader in Endocrinology and Rare Diseases

AGTC Announces Pricing of Public Offering of Common Stock and Warrants

Acorda Therapeutics Announces Agreement for Sale of Manufacturing Operations and Long-Term Global Supply Agreement for INBRIJA®, Corporate Restructuring, and Enters into “At The Market” Offering Agreement

Aytu BioScience and Neos Therapeutics Announce Definitive Merger Agreement, Creating a Combined $100M Revenue¹ Specialty Pharmaceutical Company

Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement

Press Ganey Advances Health Care Consumerism Movement with Acquisitions of Doctor.com and Majority Stake in Binary Fountain

Strongbridge Biopharma plc Announces Pricing of Public Offering of Ordinary Shares

MiNA Therapeutics Secures £23 Million Series A Financing to Advance First-inClass Activating RNA-Based Therapeutics

Verastem Oncology Signs Definitive Agreement to Sell COPIKTRA® (duvelisib) Rights to Secura Bio to Focus on Development of VS-6766 and Defactinib in KRAS Mutant Solid Tumors

Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain Program

SOC Telemed to Merge with Healthcare Merger Corp.

Aduro Biotech and Chinook Therapeutics Announce Definitive Merger Agreement

Chondrial Therapeutics and Zafgen Complete Merger and Begin Operating as Larimar Therapeutics

scPharmaceuticals Announces Pricing of Public Offering of Common Stock

Quorum Health Corporation Reaches Agreement with Majority of Lenders and Noteholders on Prepackaged Recapitalization Plan

Pager Announces $33M Financing Round

KabaFusion Acquires Lincare’s Infusion Pharmacies, Expanding Patient-Focused Home Infusion Services Nationwide

R1 Announces Agreement to Acquire SCI Solutions, a Leading Provider of Digital Patient Engagement Solutions

Bright Health to Expand into California through Planned Acquisition of Brand New Day Health Plan

Healthgrades Acquires Evariant

Gilead and Eisai Enter Into Agreement in Japan for the Co-Promotion of the Investigational Rheumatoid Arthritis Therapy Filgotinib, Pending Regulatory Approval

CareFirst BlueCross BlueShield Announces Agreements to Acquire Medicaid MCO Plans in Maryland and Washington, D.C.

Zafgen and Chondrial Therapeutics Announce Definitive Merger Agreement

Asahi Kasei Group Announces a Recommended Conditional Voluntary Public Offer for Veloxis

Blue Cross Blue Shield Of Arizona To Serve AHCCCS-Eligible Arizonans With Purchase Of Steward Health Choice Arizona

Sumitomo Dainippon Pharma and Roivant Sciences Sign Definitive Agreement for Strategic Alliance

GENESIS HEALTHCARE ENTERS INTO INVESTMENT TO BUY BACK REAL ESTATE HISTORICALLY LEASED

Lundbeck to acquire Alder BioPharmaceuticals – a company committed to transforming migraine treatment and prevention – in a transaction valued at up to USD 1.95 billion net of cash

Jazz Pharmaceuticals Announces Acquisition of Cavion, Inc.

Aquinox Pharmaceuticals and Neoleukin Therapeutics announce merger agreement

RECOMMENDED ACQUISITION OF AEGERION

Vical and Brickell Announce Merger Agreement

LifeArc monetises Keytruda® royalty interests to fund further research and investment

Agreement Reached for ESSA Pharma to Acquire Realm Therapeutics | Acquisition Expected to be Completed by Mid-Year 2019

Sagard Healthcare Royalty Partners and Newcastle University, UK Announce the Monetization of Royalty Interest in Cancer Drug, Rubraca

Paladina Health Acquires Activate Healthcare to Amplify Impact of Primary Care Nationwide

ImmunoGen Announces Sale of Residual Kadcyla Royalties

Tetra Discovery Partners and Shionogi & Co., Ltd. Collaborate on BPN14770 Development and Commercialization

Strongbridge Biopharma plc Enters into Agreement for Novo Nordisk to Acquire the U.S. and Canadian Rights to MACRILEN™ (macimorelin)

Alliqua BioMedical Inc. and Adynxx, Inc. Announce Merger Agreement to Create NASDAQ-listed Clinical-Stage Pharmaceutical Company with a Focus on Pain and Inflammation

Otsuka and Proteus Digital Health Announce Expanded Collaboration Agreement to Advance Digital Medicines for Mental Health

The MTS Biotech IPO Monitor – Edition 4: Q3 2018 Update – 2018 Looking to Beat the 2014 High Tide Mark For Biotech IPOs

The MTS Biotech Monitor – “Back to School” Edition Sept 2018 Update – Early-Stage IPO Performance: Phase I is the New Phase II

Poxel Expands Metabolic Pipeline Through Strategic Acquisition Agreement with DeuteRx for DRX-065, a Novel Clinical Stage Drug Candidate for NASH, and Other Programs

Ligand Makes Offer to Acquire Vernalis, a Leader in Structure-based Drug Discovery, for Approximately $43 Million in Cash

Protalix BioTherapeutics Expands Partnership with Chiesi Farmaceutici to Include Exclusive U.S. Rights for the Development and Commercialization of PRX-102 (pegunigalsidase alfa) for the Treatment of Fabry Disease

LifePoint Health to Merge with RCCH HealthCare Partners

The MTS Biotech IPO Monitor – Edition 3: H1 2018 Update – Will 2018 Beat the 2014 High Tide Mark For Biotech IPOs?

Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics LLC for Prialt

Akebia Therapeutics and Keryx Biopharmaceuticals to Merge, Creating a Fully Integrated Company Focused on the Development and Commercialization of Therapeutics for Patients with Kidney Disease

The MTS Biotech Monitor H1:2018 Preview – The Fourth Generation of Biotech IPOs Continues to Follow Moore’s Law – Avg GP $100M/Avg MC $400M is the New Avg GP $50M/Avg MC $200M

Barings Acquires Royalty Interest in Recombinant Therapy Vonvendi® From Boston Children’s Hospital

Sage Therapeutics and Shionogi & Co., Ltd., Enter Strategic Collaboration to Develop and Commercialize SAGE-217 for MDD and Other Indications in Japan, Taiwan and South Korea

The MTS Biotech IPO Monitor – Edition 2: Q1 2018 Update – Signs of Nervousness Or Business as Usual?

Arbutus and Roivant Launch Genevant Sciences with Industry-Leading Platform to Develop Broad Range of RNA Therapeutics for Genetic Diseases

Addex Sucessfully Raises CHF40 million in Capital Increase

pSivida Corp. Announces Transformative Acquisition of Icon Bioscience Inc. and Growth Capital Financing with Essex Woodlands Healthcare Partners – Company Will Rebrand as EyePoint Pharmaceuticals, Inc.

Cyteir Therapeutics Secures $29 Million Series B to Advance Novel, Molecularly Targeted Therapies for Cancer and Autoimmune Diseases

Strongbridge Biopharma plc Announces Acquisition of the U.S. and Canadian Rights to MACRILEN™ (macimorelin) from Aeterna Zentaris

Kazuki Kusaka Joins MTS Health Partners as Partner

Mallinckrodt Completes Acquisition of Ocera Therapeutics and OCR-002, Its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy

The MTS US Biotech IPO Monitor: 2017 Was a Banner Year – How Does This Bode For 2018, The 40th Birthday For The US Biotech IPO Market?

Charlie Ditkoff Joins MTS Health Partners as Senior Advisor

Gene Therapy – Near-term Revolution or Continued Evolution? Part 2: The Gene Therapy Ecosystem

David Low Joins MTS Health Partners as Partner

ImmusanT Raises $40 Million in Series C Financing

Mallinckrodt to Acquire Ocera Therapeutics and OCR-002, its Proprietary Therapy in Development for Treatment of Hepatic Encephalopathy

Aerie Pharmaceuticals Announces Drug Delivery Asset Acquisition to Further Advance Its Retinal Disease Program

Dimension Board Determines That Ultragenyx’s Unsolicited Proposal to Acquire Dimension for $6.00 Per Share Constitutes a “Superior Proposal”

Realm Therapeutics – Proposed Placing to raise £19.3 million

Strategic Advisory Analytics – Gene Therapy – Near-term Revolution or Continued Evolution? Part 1

Anti-cancer treatment yields up to US$325M in landmark Australian deal

Physicians Dialysis Acquires Seven Dialysis Facilities in New Jersey and Texas

Zymeworks Announces Pricing of Initial Public Offering

Strategic Advisory Analytics – Series #2: Gene Therapy – Near-term Revolution or Continued Evolution?

Verona Pharma Announces Launch of Global Offering and Application to List on the NASDAQ Global Market

Feedback note 5 #complex drug pricing in 140 characters or less

Hitachi Chemical Signs Agreement to Purchase from Caladrius Biosciences the Remaining 80.1% Interest in PCT for $75 Million

Feedback #4 on Principled Drug Pricing Report: Orphan Drug Pricing – Unlikely to be Left Alone in the Current Drug Pricing Debate

Otsuka Pharmaceutical to Acquire Neurovance, Inc.

HonorHealth announces new cancer care network

Feedback 3 on Principled Drug Pricing Report: The frictional cost break-up in drug pricing – it’s not me, it’s you

Lilly and CoLucid Pharmaceuticals Announce Agreement for Lilly To Acquire CoLucid

Ipsen to Acquire Oncology Assets from Merrimack Pharmaceuticals

OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement

Feedback 2 on Principled Drug Pricing Report: Unprincipled Price Rises – Where is the Value in an Unbearable Symptom?

RaNA Acquires Shire’s Industry Leading Messenger RNA Platform

Feedback 1 on Principled Drug Pricing Report: Will Drug Pricing Still Be as Big of an Issue Going Forward with the New Administration

WellCare to Acquire Universal American Corp.

Strategic Analytics Publishes Report on Drug Pricing: “Principled Drug Pricing Centered on Innovation and Choice: Part 1”

Auven Therapeutics Announces Sale of Ocular Technologies to Sun Pharma

Horizon Pharma plc to Acquire Raptor Pharmaceutical Corp. as Further Step in Building Leading Rare Disease Business

Dana-Farber Cancer Institute monetizes royalty interests derived from immunotherapy patents with Canada Pension Plan Investment Board

PathGroup Completes Recapitalization with Pritzker Group Private Capital

MRC Technology monetises royalties on cancer drug Keytruda® (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital

Verona Pharma plc Proposed Placing to raise c. £44.7 million (US$63.3 million)

William Stitt Joins MTS Health Partners as Partner

Jazz Pharmaceuticals And Celator Pharmaceuticals Announce Agreement For Jazz Pharmaceuticals To Acquire Celator For $30.25 Per Share

Synta and Madrigal Announce Merger Agreement to Create Leading Cardiovascular-Metabolic Diseases and NASH Company

Unum announces agreement to acquire Louisiana-based Starmount Life Insurance Company

Celator Pharmaceuticals Closes $43.7 Million Underwritten Financing

Caladrius Biosciences Subsidiary PCT, LLC Enters Into Global Collaboration and License Agreement with Hitachi Chemical

Genesis HealthCare Signs Agreement To Sell Home Health And Hospice Operations

Aprecia Pharmaceuticals Set to Advance 3D Printed Drug Pipeline with Completion of $35 Million Financing Led by Deerfield Management

Acorda to Acquire Biotie Therapies

Zymeworks Announces $61.5 Million Financing to Support the Clinical Development of its Pipeline of Azymetric™ Antibody Therapeutics

RestorGenex And Diffusion Pharmaceuticals Announce Merger Agreement

Raptor Pharmaceutical Corp. Expands Rare Disease Portfolio With the Acquisition of Quinsair(TM)

Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce $75 Million Private Placement

TeamHealth to Acquire IPC Healthcare for $1.6 Billion, Creating Leading Physician Services Organization

Celsus Therapeutics and Volution Immuno Pharmaceuticals Announce Agreement to Create Orphan Disease Company Focused on Complement C5 Inhibition

ARCA biopharma announces $37 million private placement

ImmunoGen, Inc. Announces $200 Million Non-Dilutive Royalty Transaction

TRACON Pharmaceuticals Announces Pricing of Initial Public Offering

Regado Biosciences and Tobira Therapeutics Announce Merger Agreement to Create Leading NASH Company

Otsuka Pharmaceutical to Acquire Avanir Pharmaceuticals

Acorda Therapeutics to Acquire Civitas Therapeutics

TRACON Pharmaceuticals Completes $27 Million Financing and Expands Management Team and Board of Directors

Aerie Announces $125 Million Convertible Notes

Skilled Healthcare To Combine With Genesis HealthCare In 100% Stock Transaction

Baxter Acquires AesRx, LLC, Including Its Investigational Sickle Cell Disease Treatment

Nicox to acquire Aciex Therapeutics, Inc.

Navigant Acquires Cymetrix, a Leading Healthcare Revenue Cycle Management Firm

Kaléo announces $150 million debt financing to support commercialization of EVZIO™

Promise Healthcare Assumes Operations of Six Health Care Facilities Including Four Long-Term Acute Care Hospitals and Two Skilled Nursing Facilities

Oxygen Biotherapeutics Prices $52 Million Underwriten Offering

NuPathe Terminates Agreement With Endo and Enters Into Agreement to Be Acquired by Teva

Iroko Pharmaceuticals Secures $75 Million in Debt Financing to Support ZORVOLEX™ (diclofenac) Commercialization

Almost Family, Inc. Signs Definitive Agreement to Acquire SunCrest HealthCare

Miraca Life Sciences Announces That It Has Acquired PLUS Diagnostics

La Jolla Pharmaceutical Company Announces Closing of $10 Million Financing and Capital Restructuring

Acorda Therapeutics Announces Acquisition of Two Neuropathic Pain Assets

University of Pennsylvania Sells a Portion of its Royalty Interest in Juxtapid® for $55 Million

RXI Pharmaceuticals Announces $16.4 Million Placement Of Common Stock

Amerihealth Agrees To Buy Chartered Health's Assets As Rehabilitator Seeks To Avoid Disruption In Medicaid Services

Arsenal Capital Partners Announces Recapitalization Investment In Tractmanager, Inc.

Bioscrip Enters Into Agreement To Acquire Homechoice Partners, Inc.

Genesis Healthcare Acquires Sun Healthcare Group, Inc.

Methylgene Closes Cdn.$26.1 Million Private Placement

Nupathe Announces Closing Of $28 Million Private Placement And Changes To Its Board Of Directors

Fibrocell Science, Inc. Announces $45 Million Private Placement And Enters Strategic Collaboration With Intrexon

Jazz Pharmaceuticals Enters Definitive Agreement To Sell Its Women's Health Business To Meda

Genesis Healthcare To Acquire Sun Healthcare Group, Inc.

Vince Lambert Joins MTS Health Partners As Senior Managing Director

Bioscrip Completes Sale Of Community Pharmacies And Centralized Specialty And Mail Service Pharmacy To Walgreens

Lumeris, Blues Plans Partner To Acquire Nation's Largest Real-time Health Care Communication Network

Bioscrip Sells Assets Of Specialty Pharmacies And Centralized Specialty And Mail Service Pharmacy To Walgreens

Kadmon Acquires First-in-class Ras Antagonist From Concordia Pharmaceuticals

Idenix Pharmaceuticals To Raise $61 Million In Follow On Public Offering Of Common Stock

A.P. Pharma To Raise $24 Million In Private Placement Of Common Stock And Warrants

Highmark And West Penn Allegheny Health System Announce Plans

Synageva Biopharma And Trimeris Announce Merger Agreement

Akorn Enters Into An Agreement To Acquire Advanced Vision Research

Methylgene Announces $34.5 Million Private Placement

Intercell Completes Placement Of Eur 33.0m Senior Convertible Debt Financing

Sun Healthcare Group, Inc. Announces The Acquisition Of Countryside Hospice Care, Inc.; Expands Solamor Hospice Operations

Acadia Pharmaceuticals Announces $15 Million Private Placement

Neurologix Completes Additional $7 Million Financing

Abbott And Reata Pharmaceuticals Announce Agreement To Develop And Commercialize Bardoxolone Methyl For Chronic Kidney Disease Outside The U.s.

Us Worldmeds Acquires Solstice Neurosciences

Sun Healthcare Group, Inc. Prices Public Offering Of 26,750,000 Million Shares Of Common Stock

Trubion Pharmaceuticals Announces Agreement To Be Acquired By Emergent Biosolutions

Nupathe Inc. Announces Pricing Of Initial Public Offering

Sun Healthcare Group, Inc. Announces Plan To Separate Its Operating And Real Property Assets; Adopts A Stockholder Rights Plan

Threshold Pharmaceuticals Completes $35 Million Private Equity Financing

Ligand To Acquire Neurogen For Stock And Contingent Value Rights

MTS Health Investors Acquires dna Diagnostics Center, Inc.

Threshold Pharmaceuticals Announces $18 Million Private Equity Financing

Threshold Pharmaceuticals Announces $18 Million Private Equity Financing

MTS Health Partners Announces Minority Investment By Funds Managed By Oaktree

MTS Health Partners Brings Two New Partners On Board

Apria Healthcare Signs Definitive Agreement To Acquire Coram, Inc.